Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Assessing the Role of Afg3l2 Pathogenic Variants in Parkinson's Disease

Author:Quintana, Valentina   Keller Sarmiento, Ignacio   Bustos, Bernabe   Lange, Lara M.   Lohmann, Katja   Alcalay, Roy   Morris, Huw   Marti, Maria J   Okubadejo, Njideka   Ahmad-Annuar, Azlina   Lim, Shen-Yang   Tan, Ai Huey   Shin Toh, Tzi   Tay, Yi Wen   Foroud, Tatiana   Holohan Nudelman, Kelly Nicole   Kaiyrzhanov, Rauan   Rizig, Mie   Valente, Enza M   Landoulsi, Zied   Jeon, Beomseok   Cherayil, Neena   Fang, Zih-Hua   Singleton, Andrew   Trinh, Joanne   Klein, Christine   Mencacci, Niccolo   

Session Name:P6: Movement Disorders: Parkinson's Disease Genetics, Biomarkers, and Basic Science 2  

Topic:Movement Disorders  

Program Number:P6.004  

Author Institution:Universidad Icesi, Cali, Colombia  Northwestern University, Chicago, IL  Northwestern University, IL  Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, MD  Institute of Neurogenetics, University of Lübeck, Germany  Columbia University, New York, NY  University College London, London, United Kingdom  Parkinson and Movement Disorders Unit, Hospital Clínic of Barcelona, Spain  College of Medicine, University of Lagos, Nigeria  University of Malaya, Malaysia  Indiana University School of Medicine, Indianapolis, IN  Indiana University School of Medicine, IN  University College London, United Kingdom  UCL Queen Square Institute of Neurology, United Kingdom  University of Pavia and IRCCS Mondino Foundation, Italy  Luxembourg Institute of Health, Luxembourg  Chung-Ang University Health care system, Hyundae Hospital, Seoul, Korea, Republic of  Northwestern University Memorial Hospital, Chicago, IL  German Center for Neurodegenerative Diseases (DZNE), Germany  Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD  Institute of Neurogenetics, University of Lübeck, Lübeck, Germany, Germany  University of Luebeck, Lübeck, Germany  

Describing the Population of Patients with Prolonged Seizures: US Subgroup Results from a Global Real-world Point-in-time Study

Author:Trinka, Eugen   Walker, Matthew   Kalviainen, Reetta   Haut, Sheryl   Stern, John   Hirsch, Lawrence   Gillespie, Alexander   LeBrocq, Laura   Laloyaux, Cedric   Radunz, Olaf   Wilson, J Claire   

Session Name:P7: Epilepsy/Clinical Neurophysiology (EEG): Retrospective Studies, Systematic Reviews, and Meta-analysis 2  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P7.001  

Author Institution:Department of Neurology, Neurocritical Care, and Neurorehabilitation, Member of European Reference Network EpiCARE, Center for Cognitive Neuroscience, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria  Neuroscience Institute, Center for Cognitive Neuroscience, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria  Institute of Public Health, Medical Decision Making and Health Technology Assessment, University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria, Salzburg, Austria  UCL Queen Square Institute of Neurology, Department of Clinical & Experimental Epilepsy, UCL, UK, London, United Kingdom  Department of Neurology, School of Medicine, University of Eastern Finland and Kuopio Epilepsy Center, Kuopio, Finland, Kuopio, Finland  Montefiore Medical Center, Albert Einstein Center, Albert Einstein College of Medicine, NY, USA, Bronx, NY  Department of Neurology, University of California, Los Angeles, CA, USA, Los Angeles, CA  Comprehensive Epilepsy Center, Department of Neurology, Yale University, New Haven, CT, USA, New Haven, CT  Adelphi Real World, Bollington, UK, Bollington, United Kingdom  UCB, Brussels, Belgium, Brussels, Belgium  UCB, Slough, UK, Slough, United Kingdom  

Efficacy and Safety of Frexalimab in Participants With Relapsing Multiple Sclerosis: 3-Year Results From the Phase 2 Open-label Extension

Author:Vermersch, Patrick   Krieger, Stephen   Wiendl, Heinz   Granziera, Cristina   Mao-Draayer, Yang   Cutter, Gary   Kalbus, Oleksandr   Staikov, Ivan   Dufek, Michal   Montalban, Xavier   Saubadu, Stephane   Luo, Xiaodong   Smyth, Brendan   Djukic, Biljana   Truffinet, Philippe   Wallstroem, Erik   Giovannoni, Gavin   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:Multiple Sclerosis  

Program Number:P7.003  

Author Institution:University of Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, Lille, France  Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, United States, New York, NY  Department of Neurology and Neurophysiology, University of Freiburg, Freiburg, Germany  Brain & Mind Institute, University of Sydney, Sydney, Australia, Freiburg im Breisgau, Germany  Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine  Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland  Autoimmunity Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States, Oklahoma City, OK  Department of Biostatistics, UAB School of Public Health, Birmingham, AL, United States, Birmingham, AL  Department of Neurology, Dnipro State Medical University, Dnipro, Ukraine, Dnipro, Ukraine  Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria, Sofia, Bulgaria  First Department of Neurology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic  Multiple Sclerosis Centre of Catalonia, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain , Barcelona, Spain  Sanofi, Gentilly, France, Chilly Mazarin, France  Sanofi, Morristown, NJ, United States, Morristown, NJ  Sanofi, Cambridge, MA, United States, Cambridge, MA  Queen Mary University of London, London, United Kingdom, London, United Kingdom